市场调查报告书
商品编码
1637686
北美放射肿瘤学市场预测至 2031 年 - 区域分析 - 按类型和应用North America Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application |
2023年北美放射肿瘤市值为40.4723亿美元,预计2031年将达到104.0958亿美元;预计2023年至2031年复合年增长率为12.5%。
癌症盛行率的增加推动了北美放射肿瘤学市场
癌症是对全世界社会产生重大影响的常见健康状况之一。根据世界卫生组织(WHO) 的数据,癌症是全球主要死亡原因,到2023 年,癌症将导致970 万人死亡,新增癌症病例将达到2000 万,预计到2050 年,新增癌症病例将达到约3,500 万。 7.8%、6.9%和6.8%。
癌症盛行率和发病率的不断上升创造了对有效治疗方案的需求。放射治疗是癌症患者不断发展的治疗选择之一,它利用高剂量的辐射(例如 X 射线、伽马射线等)来杀死癌细胞,具有有效的效果。放射治疗用于癌症的早期阶段,各种类型的体外放射治疗用于治疗不同的癌症。例如,近距离放射治疗用于治疗乳癌、子宫颈癌、眼癌、摄护腺癌和头颈癌。同样,全身放射治疗也称为放射性碘,用于治疗甲状腺癌。放射治疗可以在治疗的任何时间使用,并且可以与其他治疗方法结合使用,例如手术、化疗、免疫治疗等。因此,癌症盛行率的增加和肿瘤学放射治疗的发展预计将推动放射肿瘤学市场的成长。
北美放射肿瘤学市场概况
在美国,所有癌症患者都可以广泛使用放射治疗,并且对放射肿瘤科医师的需求不断增加。由于医疗基础设施的发达,这些专业人员的数量也不断增加。儘管如此,美国临床肿瘤学会估计全球约三分之二的癌症患者接受放射治疗作为治疗的一部分。到 2023 年,预计美国每年将有超过 100 万名癌症患者接受放射治疗。政府和医疗机构正在采取多项措施来鼓励采用放射治疗。 2020 年 6 月,美国放射肿瘤学会 (ASTRO) 推出了非转移性子宫颈癌放射治疗的新临床指南。新指南的重点是精确实施放射治疗的步骤和流程。
北美放射肿瘤学市场收入及 2031 年预测(百万美元)
北美放射肿瘤学市场细分
北美放射肿瘤学市场按类型、应用和国家分类。
根据类型,北美放射肿瘤学市场分为体外放射治疗和内照射放射治疗。 2023 年,体外放射治疗领域将占据更大的市场份额。
从应用来看,北美放射肿瘤市场分为乳癌、摄护腺癌、肺癌、头颈癌、子宫颈癌等。 2023 年,乳癌细分市场占据最大的市场份额。
按国家/地区划分,北美放射肿瘤学市场分为美国、加拿大和墨西哥。 2023 年,美国在北美放射肿瘤学市场份额中占据主导地位。
Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Perspective Therapeutics Inc、NTP RADIOISOTOPES、Mallinckrodt Plc、Provision Healthcare 和 Curium 是美国北方运营的一些领先公司美国放射肿瘤学市场。
The North America radiation oncology market was valued at US$ 4,047.23 million in 2023 and is expected to reach US$ 10,409.58 million by 2031; it is estimated to record a CAGR of 12.5% from 2023 to 2031.
Increasing Prevalence of Cancer Fuels North America Radiation Oncology Market
Cancer is one of the common health conditions significantly impacting society worldwide. According to the World Health Organization (WHO), cancer is the leading cause of death worldwide, accounting for 9.7 million deaths and 20 million new cancer cases in 2023 and it is expected to reach ~35 million new cancer cases by 2050. As per the WHO 2024 report, lung cancer is the most common cancer and leading cause of the death globally followed by colorectal cancer, liver cancer, breast cancer, and stomach cancer accounting for 18.7%, 9.3%, 7.8%, 6.9%, and 6.8% of the total deaths respectively.
The increasing prevalence and incidence of cancer creates demand for effective treatment options. Radiotherapy is one of evolving treatment options for cancer patients with effective outcome which utilizes the high doses of radiation such as X-rays, gamma rays, and others to kill the cancerous cells. Radiotherapy is used in the early stages of cancer and various types of external beam radiotherapy are used for the treatment of different cancers. For instance, brachytherapy is used for the treatment of breast cancer, cervix cancer, eye cancer, prostate cancer, and head & neck cancer. Similarly, Systemic radiation therapy is also known as radioactive iodine and is used for treatment of thyroid cancer. Radiation therapy can be used at any point in the treatment and can be combined with other treatments such as surgery, chemotherapy, immunotherapy and others. Therefore, increasing prevalence of cancer and evolution of radiotherapy in oncology is expected to drive the growth of radiation oncology market.
North America Radiation Oncology Market Overview
Radiation therapy is widely available for all cancer patients in the US, and the need for radiation oncologists is continuously on the rise. The number of these professionals also increases continuously owing to the developed healthcare infrastructure. Nevertheless, the American Society of Clinical Oncology approximately two-thirds of cancer patients globally are estimated to receive radiation therapy as a part of their treatment. In 2023, over 1 million cancer patients in the US are projected to undergo radiation therapy annually. The government and healthcare authorities are taking several initiatives to encourage the adoption of radiotherapy. In June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guidelines focus on precisely implementing steps and processes to conduct radiation therapy.
North America Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)
North America Radiation Oncology Market Segmentation
The North America radiation oncology market is categorized into types, application, and country.
Based on types, the North America radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.
In terms of application, the North America radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.
By country, the North America radiation oncology market is segmented into the US, Canada, and Mexico. The US dominated the North America radiation oncology market share in 2023.
Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Perspective Therapeutics Inc, NTP RADIOISOTOPES, Mallinckrodt Plc, Provision Healthcare, and Curium are some of the leading companies operating in the North America radiation oncology market.